rs145668843

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 2P and 14B. PM1BP4_ModerateBP6_Very_StrongBS2

The NM_004006.3(DMD):ā€‹c.696C>Gā€‹(p.Ile232Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000359 in 1,207,499 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 132 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.00022 ( 0 hom., 4 hem., cov: 23)
Exomes š‘“: 0.00037 ( 0 hom. 128 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

9
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.51
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

PM1
In a region_of_interest Actin-binding (size 239) in uniprot entity DMD_HUMAN there are 5 pathogenic changes around while only 1 benign (83%) in NM_004006.3
BP4
Computational evidence support a benign effect (MetaRNN=0.24008453).
BP6
Variant X-32699247-G-C is Benign according to our data. Variant chrX-32699247-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 284717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-32699247-G-C is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 4 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DMDNM_004006.3 linkuse as main transcriptc.696C>G p.Ile232Met missense_variant 8/79 ENST00000357033.9 NP_003997.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkuse as main transcriptc.696C>G p.Ile232Met missense_variant 8/791 NM_004006.3 ENSP00000354923 P4

Frequencies

GnomAD3 genomes
AF:
0.000215
AC:
24
AN:
111607
Hom.:
0
Cov.:
23
AF XY:
0.000118
AC XY:
4
AN XY:
33839
show subpopulations
Gnomad AFR
AF:
0.0000649
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000287
Gnomad ASJ
AF:
0.00114
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000283
Gnomad OTH
AF:
0.000668
GnomAD3 exomes
AF:
0.000224
AC:
41
AN:
182849
Hom.:
0
AF XY:
0.000237
AC XY:
16
AN XY:
67575
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000110
Gnomad ASJ exome
AF:
0.00174
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000295
Gnomad OTH exome
AF:
0.000222
GnomAD4 exome
AF:
0.000374
AC:
410
AN:
1095892
Hom.:
0
Cov.:
29
AF XY:
0.000354
AC XY:
128
AN XY:
361506
show subpopulations
Gnomad4 AFR exome
AF:
0.0000380
Gnomad4 AMR exome
AF:
0.0000853
Gnomad4 ASJ exome
AF:
0.00124
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000430
Gnomad4 OTH exome
AF:
0.000457
GnomAD4 genome
AF:
0.000215
AC:
24
AN:
111607
Hom.:
0
Cov.:
23
AF XY:
0.000118
AC XY:
4
AN XY:
33839
show subpopulations
Gnomad4 AFR
AF:
0.0000649
Gnomad4 AMR
AF:
0.000287
Gnomad4 ASJ
AF:
0.00114
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000283
Gnomad4 OTH
AF:
0.000668
Alfa
AF:
0.000521
Hom.:
4
Bravo
AF:
0.000257
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000692
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000743
AC:
5
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJun 24, 2019This variant is associated with the following publications: (PMID: 26392559) -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 09, 2017The p.Ile232Met variant (rs145668843) has not been reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the Genome Aggregation Database (gnomAD) with an overall population frequency of 0.02 percent (identified on 40 out of 199,721 chromosomes, including 17 hemizygotes), and has been reported to the ClinVar database as a likely benign variant (Variation ID: 284717). The isoleucine at position 232 is moderately conserved considering 7 species (Alamut v2.10) and computational analyses of the p.Ile232Met variant on protein structure and function indicate a neutral effect (GVGD: class C0, MutationTaster: polymorphism, PolyPhen-2: benign). Overall this variant is considered to be likely benign. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 03, 2016- -
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Likely benign, no assertion criteria providedclinical testingNatera, Inc.Nov 21, 2017- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsNov 14, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Duchenne muscular dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 17, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.0099
T
BayesDel_noAF
Uncertain
0.040
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.64
.;D;.;.;D
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.74
T;.;T;T;T
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.24
T;T;T;T;T
MetaSVM
Uncertain
0.54
D
MutationTaster
Benign
0.93
N;N;N
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.1
.;N;.;N;N
REVEL
Uncertain
0.55
Sift
Uncertain
0.0050
.;D;.;D;D
Sift4G
Uncertain
0.0040
D;D;D;D;D
Polyphen
0.046, 0.0020
.;B;.;.;B
Vest4
0.64
MVP
0.94
MPC
0.021
ClinPred
0.060
T
GERP RS
2.8
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145668843; hg19: chrX-32717364; API